Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Oxford Cannabinoid Technologies Holdings Plc OCTHF OTC

Other OTC • Healthcare • Biotechnology • GB • USD

SharesGrow Score
36/100
1/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Oxford Cannabinoid Technologies Holdings Plc (OCTHF) is a Biotechnology company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 33/100, indicating a weak investment profile with 1 out of 7 criteria passed.

Net income is $6M (loss), growing at -41.9%/yr. Net profit margin is 0% (thin). Gross margin is 0% (+0 pp trend).

Balance sheet: total debt is $0 against $4M equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 7.69 (strong liquidity). Debt-to-assets is 0%. Total assets: $4M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 0/100 (Fail), Health 100/100 (Pass), Moat 28/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

OCTHF SharesGrow Score Overview

48/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 28/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — OCTHF

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✗
GROWTH Fail
15/100
OCTHF: +0%/yr revenue is, -41.9%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✓
HEALTH Pass
100/100
Balance sheet OCTHF: Debt-to-Equity (D/E) ratio 0 (conservative), Current ratio is 7.69 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
28/100
OCTHF: Gross margin is 0% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 28/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range0.0028-0.0419
Volume45.11K
Avg Volume (30D)6.19K
Market Cap$3.05M
Beta (1Y)3.63
Share Statistics
EPS (TTM)-0.01
Shares Outstanding$960.42M
IPO Date2021-10-20
Employees5
CEOClarissa Ann Sowemimo-Coker
Financial Highlights & Ratios
Gross Profit$-4.3M
EBITDA$-7M
Net Income$-5.95M
Operating Income$-7.04M
Total Cash$2.3M
Net Debt$-2.3M
Total Assets$4.5M
Price / Earnings (P/E)-0.5
Analyst Forecast
Company Info
CountryGB
ExchangeOther OTC
CurrencyUSD
ISINGB00BMVMRB86

Price Chart

Track all markets on TradingView
OCTHF
Oxford Cannabinoid Technologies Holdings Plc ↗  ·  Other OTC
Healthcare • Biotechnology
0.00 52WK RANGE 0.04

People Also View

PHGUF
PHGUF
Pharming Group N.V.
$1.75
+15.89%
 MMIRF
MMIRF
MedMira Inc.
$0.05
+0.00%
 KNBIF
KNBIF
Kane Biotech Inc.
$0.02
-3.64%
 HESG
HESG
Health Sciences Group, Inc.
$0.00
+0.00%
 NTII
NTII
Neurobiological Technologies, Inc.
$0.00
+0.00%
 LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message